2 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow avoralstat: new trials by email Literature Review of avoralstat trials Research Report on avoralstat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks BCX4161, Placebo - Hereditary Angioedema, HAE | Phase 2 / Phase 3 | Completed | BioCryst Pharmaceuticals | 110 | 2014-12-17 | 2025-11-17 |
| Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE BCX4161, Placebo - Hereditary Angioedema | Phase 2 | Completed | BioCryst Pharmaceuticals | 24 | 2013-11-01 | 2014-08-18 |
Germany (2) · United Kingdom (2) · Belgium (1) · Canada (1) · France (1) · Hungary (1) · Italy (1) · United States (1)
Marc Riedl, MD MS (1) · Marcus Maurer, MD (1)